• Journal of Korean Academy of Nursing
• /
• v.22 no.1
• /
• pp.68-80
• /
• 1992

In order to provide data basic to the training of hospice volunteers, this study was carried out to investigate the personal attributes and the Death Orientation of hospice volunteers. 80 hospice volunteers were sampled from those registered on Seoul Catholic Social Service and Korean Association for Volunteers Effort conveniently. Data were gathered from August 16th to October 3rd, 1991. The instrument used for this study was the Death Orientation Questionnaire developed by Thorson and Powell, subjective age and religiosity questionnaire developed by Bell and Batterson, and subjective health criteria developed by Baumann. Data were analyzed using frequency, mean, standard deviation, Chi-square, and t-test by SPSS - program. Result of this study are summarized as follows ; 1. The majority of hospice volunteers perceived younger in their subjective age than their chronological age (65%), Perceived themselves to be healthy subjectively(88.8%), and revealed to have high religiosity score(96.3%) 2. Level of Death Orientation of hospice volunteers was revealed to be moderate.(Mn＝2.06, SD＝0.40, range, 1.45-3.53) Among 25 Death Orientation items, respondents revealed the highest concern over the afterlife (Mn＝3.53, SD＝0.71), revealed the lowest anxiety about not knowing the next world after his or her death(Mn＝1.45, SD＝0.69), and relatively high concern over leaving careful instructions after death (Mn＝2.97, SD＝0.83) Respondents revealed low Death Orientation score(below 1.99) to 12 negative items(2, 3, 5, 6, 7, 9, 14, 17, 18, 19, 20, 22). Thus hospice volunteers seem to be preparing for their own death and shown positive Death Orientation to some items relatively. 3. According to personal attributes (demographic, socioecnomic, and relevant variables) of hospice volunteers, there were no significant statistic differences of Death Orientation score. Thus pre-existing Death Orientation of hospice volunteers and their motive of participation to the hospice service are to be considered important variables influencing the Death Orientation.

• Food Science and Biotechnology
• /
• v.14 no.4
• /
• pp.540-542
• /
• 2005

Juice Valley and Gogu Valley were administered to twelve healthy young volunteers for 4 weeks to study their clinical effects on human intestinal microflora. Changes in fecal microflora, fecal moisture, and fecal pH were observed for Juice Valley intake. Administration of Juice Valley significantly increased numbers of Bifidobacterium and Lactobacillus from 8.69 and 7.02 to 10.89 and 9.02 (Log CFU/g wet feces), respectively, whereas those of Clostridium perfringens and Escherichia coli decreased. Moisture content of feces increased, and fecal pH decreased after 4 weeks of Juice Valley intake, intake of Gogu Valley slightly increased growth responses of Bifidobacterium and Lactobacillus and decreased growth responses of C. perfringens and E. coli. Su-mi potato, as a reference, had no effect on Bifidobacterium and Lactobacillus numbers. This study confirmed Juice Valley has better effects than Gogu Valley and Su-mi, and has important role on growth promotion and inhibition of human intestinal bacteria.

• Proceedings of the PSK Conference
• /
• 2003.04a
• /
• pp.307.2-308
• /
• 2003

The bioequivalence of two 12.72 mg domperidone maleate tablets (Sinil “perinal$\^$ⓡ/” tablets vs. Janssen Korea “Motirium-M$\^$ⓡ/” tablets) was assessed in healthy volunteers after oral administration of two tablets in a randomized crossover study. Blood samples were collected at specified time intervals, and plasma was analyzed for domperidone base using a validated HPLC method. (omitted)

• Biomolecules & Therapeutics
• /
• v.6 no.4
• /
• pp.417-422
• /
• 1998

Loxoprofen sodium (sodium 2-[4-(2-oxocyclopentylmethyl)phenyl] propionate dehydrate) is a nonsteroidal antiinflammatory drug of $\alpha$-phenyl propionic acid derivative. To test the bioequivalence of loxoprofen, the pharmacokinetic parameters of new preparation of loxoprofen, LENOX was compared with LOXONIN as a reference drug. Fourteen healthy volunteers were entered to the stydy (Yonsei University College of Medicine, Severance Hospital IRB approval No. 9608). They were administered 60 mg of loxoprofen in 2$\times$2 cross-over design. There was one week of drug-free interval between doses. The blood sample was taken on schedule up to 8 hours, and the plasma concentration loxoprofen was measured by reverse phase high-performance liquid chromatography (HPLC) with UV-detector. There were no significant difference between two preparations when AUC, Cmax, and Tmax were compared by ANOVA. The mean differences of AUC, Cmax, and Tmax were within 20% of the reference drug: the values were 2.22,5.61, and 12.50%, respectively. The confidence limits of AUC and Cmax but not Tmax satisfied the bioequivalence criteria. These results suggest that the tested LENOX is bioequivalent to the reference drug.

• Proceedings of the PSK Conference
• /
• 2002.10a
• /
• pp.420.1-420.1
• /
• 2002

The purposes of this study were to evaluate bioequivalence (BE) using In-transformed pharmacokinetic parameters obtained from two tiropramide HCI products and to develop the analytical methods for the quantitative determination of tiropramide in human serum. In addition. the in vitro dissolution profiles of the two tiropramide HCI products in various dissolution media: pH 1.2, 4.0. 6.8 and water (KP Ⅶ Apparatus II method) were assessed. BE was evaluated in 20 healthy male Korean volunteers in randomized crossover study. (omitted)

• Proceedings of the PSK Conference
• /
• 2003.10b
• /
• pp.242.1-242.1
• /
• 2003

The bioequivalence of two tablet formulations of 12.72 mg domperidone maleate (Shinpoong "$\textrm{Dompi}^{?}$" tablets vs. Janssen Korea "$\textrm{Dompi}^{?}$" tablets) was assessed in healthy Korean volunteers after oral administration in a randomized crossover study. Blood samples were collected at specified time intervals, and plasma concentration was measured as the amount of domperidone base using a validated HPLC method. The pharmacokinetic parameters of $AUC_{0{\longrightarrow}48}$, $C_{max}$, $T_{max}$$t\frac{1}{2}$ were determined from plasma concentration-time profile of two formulations. (omitted)

• Proceedings of the PSK Conference
• /
• 2003.04a
• /
• pp.307.1-307.1
• /
• 2003

Metfotrmin is a biguanide antihyperglycemic agent often used for the treatment of non-insulin dependent diabetics(NIDDM). Metformin lowers both fasting and postprandial plasma glucose concentrations by improving insulin sensitivity at hepatic and peripheral tissues. The pharmacokinetics and pharmacodynamics of metformin were studied in Korean healthy volunteers at fasting state over 10 hours. (omitted)

• Proceedings of the PSK Conference
• /
• 2003.10b
• /
• pp.240.3-241
• /
• 2003

The purpose of this trial was to determine pharmacokinetic parameters and to characterize bioavailability of levosulpiride after oral administration in Korean healthy male volunteers. Thirty subjects were received a single oral dose of a tablet (Isomeric$\^$\ulcorner/) containing 25 mg of levosulpiride. The plasma concentrations of levosulpiride were measured by a validated FLD-HPLC method and compared with those reported in the literature. Levosulpride was absorbed slowly, revealing peak concentrations between 4 and 6 hr after oral administration. (omitted)

• Proceedings of the Korean Society of Life Science Conference
• /
• 2005.09a
• /
• pp.69-69
• /
• 2005

• Proceedings of the Korean Society for Emotion and Sensibility Conference
• /
• 2009.05a
• /
• pp.15-15
• /
• 2009